8-K: China Pharma Holdings Announces 1-for-10 Reverse Stock Split
Press Release
China Pharma Holdings Inc. will implement a 1-for-10 reverse stock split on April 15, 2025.
Summary
- China Pharma Holdings Inc. announced a 1-for-10 reverse stock split.
- The reverse stock split will be effective on Tuesday, April 15, 2025, with trading to begin on a split-adjusted basis that day.
- The company's common stock will continue to trade on the NYSE American under the symbol CPHI.
- The new CUSIP number for the common stock following the reverse stock split is 16941T 401.
- The reverse stock split was authorized by the Board of Directors on October 22, 2024, and adopted by stockholders on December 22, 2024.
- The Board fixed the ratio of 1:10 on March 26, 2025.
- Every 10 shares of issued and outstanding common stock will be converted into one share.
- No fractional shares will be issued; instead, they will be rounded up to the next whole number.
- The reverse stock split will not alter any stockholder's percentage interest in the company's outstanding common stock, except for adjustments from fractional shares.
Sentiment
Score: 5
Explanation: The announcement is a neutral corporate action. Reverse stock splits can be viewed positively or negatively depending on the underlying reasons and company performance.
Positives
- The reverse stock split affects all stockholders uniformly, maintaining their percentage interest (except for fractional share adjustments).
Risks
- The press release includes a safe harbor statement regarding forward-looking statements, indicating potential risks and uncertainties that could affect actual results.
Future Outlook
The company's future performance is subject to risks and uncertainties, as detailed in their filings with the SEC.
Industry Context
Reverse stock splits are often used by companies to increase their stock price to meet minimum listing requirements or to make the stock more attractive to investors.
Stakeholder Impact
- Shareholders will see a reduction in the number of shares they hold, but their percentage ownership will remain the same (excluding fractional share adjustments).
Key Dates
| Date | Description |
|---|---|
| October 22, 2024 | Reverse stock split authorized by the Board of Directors. |
| December 22, 2024 | Reverse stock split adopted by the Company's stockholders. |
| March 26, 2025 | Board fixed the reverse stock split ratio at 1:10. |
| April 4, 2025 | Press release announcing the reverse stock split. |
| April 15, 2025 | Effective date of the 1-for-10 reverse stock split. |
Keywords
reverse stock split, China Pharma Holdings, CPHI, stock split, NYSE American, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.